This inventor holds 4 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Nanyang Technological University, Agency for Science, Technology and Research, National Skin Center (S) Pte Ltd. Active years: 2018-2025.
Company Filing History:
4 out of 679 
2 out of 1,557 
2 out of 2 Years Active: 2018-2025
Title: Sierin Lim: Innovator in Therapeutic Delivery Systems
Introduction
Sierin Lim is a prominent inventor based in Singapore, known for his contributions to the field of therapeutic delivery systems. With a total of 4 patents, Lim has made significant strides in developing innovative solutions for medical applications.
Latest Patents
One of Lim's latest patents focuses on the targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages. This invention relates to protein nanocages that comprise a melanocyte-targeting moiety and pharmaceutical compositions that utilize these protein cages. The methods developed aim to treat or diagnose hyperpigmentation disorders and other melanocyte-related conditions. In the preferred embodiment, the protein nanocage is composed of the E2 protein of the pyruvate dehydrogenase multi-enzyme complex, featuring a skin-penetrating and cell-permeating SPACE moiety, along with a melanocyte-targeting moiety derived from alpha melanocyte-stimulating hormone.
Career Highlights
Sierin Lim has worked with notable institutions such as Nanyang Technological University and the National Skin Center Pte Ltd. His work in these organizations has contributed to advancements in skin health and therapeutic innovations.
Collaborations
Lim has collaborated with esteemed colleagues, including Sathyamoorthy Bhaskar and Steven Thng, to further enhance the impact of his research and inventions.
Conclusion
Sierin Lim's innovative work in the field of therapeutic delivery systems showcases his commitment to advancing medical science. His patents reflect a deep understanding of the complexities involved in treating melanocyte-related disorders.